Title:International Vaccine Allocation: An Optimization Framework

Abstract:The global SARS-CoV-2 (COVID-19) pandemic highlighted the challenge of equitable vaccine distribution between high- and low-income countries. High-income countries, such as the United States, were among the first to acquire the rapidly developed vaccines against COVID-19. However, many such high-income countries were reluctant or slow to distribute extra doses of the vaccine to lower-income countries via the COVID-19 Vaccines Global Access (COVAX) collaboration [Clinton and Yoo 2022]. In addition to moral objections to such vaccine nationalism, vaccine inequity during a pandemic could contribute to the evolution of new variants of the virus and possibly increase total deaths, including in the high-income countries. This paper uses the COVID-19 pandemic as a case study to identify scenarios under which it might be in a high-income nation's own interest to donate vaccine doses to another country before its own population has been fully vaccinated. Using an epidemiological model embedded in an optimization framework, we identify realistic scenarios under which a donor country prefers to donate vaccines before distributing them locally in order to minimize local deaths. We demonstrate that a nondonor-first vaccination policy can, under some circumstances, dramatically delay the emergence of more-contagious variants. Moreover, we find that vaccine distribution is not a zero-sum game between donor and nondonor countries: weighting the objective function even slightly in favor of minimizing total deaths can achieve dramatic reduction in total deaths with only a small increase in donor-country deaths. The insights yielded by this framework can be used to guide equitable vaccine distribution in future pandemics.